Duration of aromatase inhibitor use and long-term cardiovascular risk in breast cancer survivors.
Huang Y, Kwan ML, Heckbert SR, Smith NL, Othus M, Laurent CA, Roh JM, Rillamas-Sun E, Lee VS, Kolevska T, Cheng RK, Irribarren C, Nguyen-Huynh M, Hershman DL, Kushi LH, Greenlee H.
Huang Y, et al. Among authors: cheng rk.
JNCI Cancer Spectr. 2025 Jan 28:pkaf009. doi: 10.1093/jncics/pkaf009. Online ahead of print.
JNCI Cancer Spectr. 2025.
PMID: 39873699